| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/20/2000 | DE19855704A1 Mittel zur Behandlung der Symptome der Parkinsonschen Krankheit Agents for treating the symptoms of Parkinson's disease |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2360560A1 Contrast media for angiography |
| 07/19/2000 | EP1020439A1 Cetp activity inhibitors |
| 07/19/2000 | EP1020434A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019406A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 07/19/2000 | EP1019374A1 Polymorphs of donepezil hydrochloride and process for production |
| 07/19/2000 | EP1019373A1 Novel human nk 3? receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 07/19/2000 | EP1019367A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
| 07/19/2000 | EP1019360A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019075A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 07/19/2000 | EP1019052A1 Alpha 1a adrenergic receptor antagonists |
| 07/19/2000 | EP1019051A1 Peripherally acting anti-pruritic opiates |
| 07/19/2000 | EP1018879A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses |
| 07/19/2000 | CN1260791A 3-benzylpiperidine |
| 07/19/2000 | CN1054602C Meta-nisoldipine and synthesizing method thereof |
| 07/19/2000 | CN1054594C Inhibition of unsaturated monomers with 7-aryl quinone methides |
| 07/18/2000 | US6090958 N-(8-carboxyoctyl)-o-hydroxybenzamide and salts |
| 07/18/2000 | US6090945 Tetrahydro-beta-carbolines |
| 07/18/2000 | US6090824 Therapeutic neurokinin receptor antagonist compounds |
| 07/18/2000 | US6090809 1-(4-arylpiperazin-1-yl)-ω-[n-(α..omega.-dicarboximido)]-alkanes useful as uro-selective α1 -adrenoceptor blockers |
| 07/18/2000 | US6090808 Dimeric piperidine, tetrahydropyridine and piperazine derivatives |
| 07/18/2000 | US6090787 Antithrombotic agents |
| 07/18/2000 | CA2183954C Treatment of obsessive-compulsive disorders with 5-ht2 antagonists |
| 07/18/2000 | CA2003289C Use of trifluoromethylphenyl-tetrahydropyridines for the preparation of pharmaceutical compositions useful for the treatment of anxiety and anxio-depressive disorders |
| 07/13/2000 | WO2000040558A1 Aspartic protease inhibitors |
| 07/13/2000 | WO2000040550A1 Method for preparing nitroxides |
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | DE19900576A1 New substituted allyl-, glycidyl- or hydroxypropyl-benzene derivatives, used as intermediates for drugs, especially central nervous system drugs, particularly the antidepressants paroxetine and femoxetine |
| 07/12/2000 | EP1017664A1 C3a receptor ligands |
| 07/12/2000 | EP1017658A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
| 07/12/2000 | EP1017395A1 Method for treating premenstrual or late luteal phase syndrome |
| 07/12/2000 | EP1017385A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/12/2000 | EP0792289B1 Low molecular weight peptidomimetic growth hormone secretagogues |
| 07/12/2000 | EP0792266B1 N-hydroxypiperidines as superoxide radicals scavengers |
| 07/11/2000 | US6087399 Sulfonamide-substituted compounds, process for their preparation, their use as a medicament or diagnostic, and a medicament comprising them |
| 07/11/2000 | US6087379 Cyclic amine derivatives |
| 07/11/2000 | US6087367 Potent inducers of terminal differentiation and methods of use thereof |
| 07/11/2000 | US6087346 Sigma receptor ligands and the use thereof |
| 07/06/2000 | WO2000039123A1 Process for the preparation of an acetate salt of paroxetine or paroxetine analogues |
| 07/06/2000 | WO2000039093A1 Process for producing organic compound having nitroxide free radical |
| 07/06/2000 | WO2000039092A1 HETEROCYCLIC AMIDES AS INHIBITORS OF FACTOR Xa |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039090A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 07/06/2000 | WO2000039088A1 Glucagon antagonists/inverse agonists |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000039077A2 Thyroid receptor ligands |
| 07/06/2000 | WO2000039070A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | WO2000039062A1 Liquid crystalline trifluoro-substituted compounds |
| 07/06/2000 | WO2000039055A1 Rapid purification by polyaromatic quench reagents |
| 07/06/2000 | WO2000038813A1 Dehydration process |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038685A1 Solution phase synthesis of compounds including amine alcohol functionality |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | DE19961467A1 Purification of 2,2,6,6-tetramethyl-4-piperidone, useful in synthesis of stabilizers, e.g. for polymers, comprises removing tarry constituents and rectification |
| 07/06/2000 | CA2358315A1 Ortho-diphenol compounds, methods and pharmaceutical compositions for inhibiting parp |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356319A1 Thyroid receptor ligands |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356214A1 Heterocyclic amides as inhibitors of factor xa |
| 07/06/2000 | CA2353480A1 Dehydration process |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/05/2000 | EP1015447A1 Piperidinylmethyloxazolidinone derivative |
| 07/05/2000 | EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015417A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
| 07/05/2000 | EP1015405A1 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 07/05/2000 | EP1014962A1 Antithrombotic agents |
| 07/05/2000 | EP0759904B1 Process and diastereomeric salts useful for the optical resolution of racemic 4-[4-[-4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzene acetic acid. |
| 07/05/2000 | EP0726894B1 Short-acting dihydropyridines |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/05/2000 | EP0639180B1 Process for stereospecific hydrolysis of piperidinedione derivatives |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1259121A Novel sulfonamide derivatives |
| 07/05/2000 | CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use |
| 07/05/2000 | CN1259114A Polymerization inhibition of acrylates using blends of nitroxides |
| 07/05/2000 | CN1054123C Process for producing carbamic acid derivatives |
| 07/04/2000 | US6084097 Methods for preparing 1-[4-arylpiperazin-1-yl]-3-[2-oxopyrrolidin/piperidin-1-yl] propanes |
| 07/04/2000 | US6083950 Treatment of peripheral vascular disease, congestive heart failure, hypertension and especially benign prostatic hypertrophy |
| 07/04/2000 | US6083943 For treatment of gastrointestinal disorders, central nervous system disorders, allergy, inflammatory diseases, asthma, pain, emesis or migraine in mammals, especially humans |
| 06/29/2000 | WO2000037445A1 Alkyl esters of 3-(3,4-dihalogenophenyl)-2,6-dioxopiperidine-3-propionic acid useful as intermediates |
| 06/29/2000 | WO2000037443A1 Process for preparing arylpiperidine carbinol intermediates and derivatives |
| 06/29/2000 | WO2000037437A1 Novel herbicides |
| 06/29/2000 | WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |